Prescription Drug Search
Product Request Form
Alemtuzumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Alemtuzumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about NationDrugs.to
List of countries where we can ship Alemtuzumab:
- Albania
- Australia
- Austria
- Azerbaijan
- Belgium
- Belize
- China
- Cyprus
- Denmark
- Dominican Republic
- Fiji
- Finland
- Georgia
- Germany
- Gibraltar
- Greece
- Hungary
- India
- Italy
- Jamaica
- Jordan
- Kuwait
- Latvia
- Lebanon
- Liechtenstein
- Lithuania
- Monaco
- Norway
- Poland
- Qatar
- Romania
- Russian Federation
- Saint Lucia
- Serbia
- Slovenia
- Tunisia
- Ukraine
- United Arab Emirates
- United Kingdom, UK
- United States, US
Latest news releases on Alemtuzumab:
Alemtuzumab — Wikipédia
L'alemtuzumab (commercialisé sous les noms de Campath, MabCampath, Campath-1H et plus récemment de Lemtrada) est un anticorps monoclonal IgG1 kappa humanisé ...
Alemtuzumab - Wikipedia
L'alemtuzumab è un anticorpo monoclonale umanizzato utilizzato contro la leucemia linfatica cronica. Per il suo meccanismo di azione favorisce la riuscita della lisi ...
Alemtuzumab ATC Sınıflaması - Alemtuzumab etkin maddesi
Alemtuzumab etkin maddesi hakkında kısa bilgi. B-hücreli kronik lemfositik lösemide, rekombinant insan monoklonal antikoru. Haftada 3 gün 30mg/gün.
Alemtuzumab (Campath) - Medical Clinical Policy Bulletins ...
Number: 0764. Policy. Aetna considers alemtuzumab (Campath) medically necessary for the treatment of any of the following conditions:
Alemtuzumab to Treat Severe Aplastic Anemia - Full Text ...
This study will evaluate the safety and usefulness of a new immunosuppressive drug, alemtuzumab (Campath ), in patients with severe aplastic anemia (SAA). SAA is a ...
Campath (ALEMTUZUMAB) Package Insert
Return to Table of Contents. Campath ® (ALEMTUZUMAB) DESCRIPTION. Campath ® (Alemtuzumab) is a recombinant DNA-derived humanized monoclonal antibody (Campath-1H ...
Alemtuzumab CARE-MS Trials Published - Latest Medical News ...
Full results of phase 3 trials of alemtuzumab confirm reductions in relapse rates in patients with MS, and in 1 trial, reduction in sustained accumulation of ...
Relapsing MS Infusion Treatment | LEMTRADA® (alemtuzumab)
Get to know LEMTRADA. Hear from patients & specialists, find helpful resources & locate MS events near you. Learn more. See risks & benefits.
Informationen zum kostenfreien Bezug von MabCampath ...
Informationen zum kostenfreien Bezug von MabCampath (Alemtuzumab) nach Rücknahme der Zulassung. Nach der europaweiten Rücknahme der Zulassung von MabCampath ...
Alemtuzumab para la esclerosis múltiple | Cochrane
En los pacientes con EM recurrente-remitente, el alemtuzumab 12 mg fue mejor que el interferón beta-1a subcutáneo para los siguiente resultados evaluados a los 24 ...
